Search Results - "Vindeløv, L"

Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation by Baron, F, Labopin, M, Niederwieser, D, Vigouroux, S, Cornelissen, J J, Malm, C, Vindelov, L L, Blaise, D, Janssen, J J W M, Petersen, E, Socié, G, Nagler, A, Rocha, V, Mohty, M

“…This report investigated the impact of graft-versus-host disease (GVHD) on transplantation outcomes in 1859 acute myeloid leukemia patients given allogeneic…”
Get full text

The 1170 A-P single-nucleotide polymorphism (SNP) in the Her-2 neu protein (HER2) as a minor histocompatibility antigen (mHag) by Wenandy, L, Kollgaard, T, Letsch, A, Andersen, R S, Stather, D, Seremet, T, Svane, I M, Vindeløv, L, Andersen, M H, thor Straten, P

Get full text

Flow cytometric assessment of lymphocyte subsets, lymphoid progenitors, and hematopoietic stem cells in allogeneic stem cell grafts by THEILGAARD-MÖNCH, K, RAASCHOU-JENSEN, K, PALM, H, SCHJØDT, K, HEILMANN, C, VINDELØV, L, JACOBSEN, N, DICKMEISS, E

“…Currently, bone marrow (BM), cord blood (CB), and G-CSF-mobilized peripheral blood progenitor cells (PBPCs) are the most commonly used sources for allogeneic…”
Get full text

Haematopoietic cell transplantation with non-myeloablative conditioning in Denmark: disease-specific outcome, complications and hospitalization requirements of the first 100 transplants by Kornblit, B, Masmas, T, Madsen, H O, Ryder, L P, Svejgaard, A, Jakobsen, B, Sengeløv, H, Olesen, G, Heilmann, C, Dickmeiss, E, Petersen, S L, Vindeløv, L

“…We analysed the outcome and hospitalization requirements of the first 100 patients (Hodgkin's disease (HD), N =13; multiple myeloma (MM), N =14; CLL, N =12;…”
Get full text

Increased Risk of Chronic Graft-Versus-Host Disease, Obstructive Bronchiolitis, and Alopecia With Busulfan Versus Total Body Irradiation: Long-Term Results of a Randomized Trial in Allogeneic Marrow Recipients With Leukemia by Ringdén, O., Remberger, M., Ruutu, T., Nikoskelainen, J., Volin, L., Vindeløv, L., Parkkali, T., Lenhoff, S., Sallerfors, B., Mellander, L., Ljungman, P., Jacobsen, N.

“…Leukemic patients receiving marrow from HLA-identical sibling donors were randomized to treatment with either busulfan 16 mg/kg (n = 88) or total body…”
Get full text

Natural T-cell responses against minor histocompatibility antigen (mHag) HY following HLA-matched hematopoietic cell transplantation: what are the requirements for a 'good' mHag? by Kollgaard, T, Hadrup, S Reker, Petersen, S L, Masmas, T N, Andersen, M H, Spierings, E, Vindeløv, L, thor Straten, P

Get full text

A comparison of T-, B- and NK-cell reconstitution following conventional or nonmyeloablative conditioning and transplantation with bone marrow or peripheral blood stem cells from human leucocyte antigen identical sibling donors by PETERSEN, S. L, RYDER, L. P, BJÖRK, P, MADSEN, H. O, HEILMANN, C, JACOBSEN, N, SENGELØV, H, VINDELØV, L. L

“…This retrospective study compares the reconstitution of T, B and NK cells in three groups of patients transplanted for haematological malignancies with grafts…”
Get full text

Allogeneic split-skin grafting in stem cell transplanted patients by Berg, J.O, Vindeløv, L, Schmidt, G, Drzewiecki, K.T

“…Summary We present a unique case of a bone marrow stem cell transplanted (BMT) patient with cutaneous chronic Graft versus Host Disease (cGvHD) who underwent…”
Get full text

Progression and CSF Inflammation after Eradication of Oligoclonal Bands in an MS Patient Treated with Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma by Braendstrup, P., Langkilde, A.R., Schreiber, K., Ravnborg, M., Sellebjerg, F., Vindeløv, L.

“…Background: Allogeneic hematopoietic cell transplantation (allo-HCT) has been proposed as treatment for multiple sclerosis (MS) and other autoimmune diseases…”
Get full text

Evidence for involvement of clonally expanded CD8 T cells in anticancer immune responses in CLL patients following nonmyeloablative conditioning and hematopoietic cell transplantation by KOLLGAARD, T, PETERSEN, S. L, HADRUP, S. Reker, MASMAS, T. N, SEREMET, T, ANDERSEN, M. H, MADSEN, H. O, VINDELØV, L, THOR STRATEN, P

“…We have analyzed the clonotype composition of CD8+ T cells following nonmyeloablative (NMA) conditioning and hematopoietic cell transplantation (HCT), of…”
Get full text

Treatment of poor graft function after allogeneic hematopoietic cell transplantation with a booster of CD34-selected cells infused without conditioning by Askaa, B, Fischer-Nielsen, A, Vindeløv, L, Haastrup, E K, Sengeløv, H

Get full text

A Randomized Trial Comparing Busulfan With Total Body Irradiation as Conditioning in Allogeneic Marrow Transplant Recipients With Leukemia: A Report From the Nordic Bone Marrow Transplantation Group by Ringdén, Olle, Ruutu, Tapani, Remberger, Mats, Nikoskelainen, Jukka, Volin, Liisa, Vindelov, Lars, Parkkali, Terttu, Lenhoff, Stig, Sallerfors, Bengt, Ljungman, Per, Mellander, Lotta, Jacobsen, Niels

“…Between October 1988 and December 1992, 167 patients with leukemia receiving marrow transplants from HLA-identical donors and conditioned with cyclophosphamide…”
Get full text

The outcome of allo-HSCT for 92 patients with myelofibrosis in the Nordic countries by Abelsson, J, Merup, M, Birgegård, G, WeisBjerrum, O, Brinch, L, Brune, M, Johansson, P, Kauppila, M, Lenhoff, S, Liljeholm, M, Malm, C, Remes, K, Vindelöv, L, Andréasson, B

“…Between 1982 and 2009 a total of 92 patients with myelofibrosis (MF) in chronic phase underwent allo-SCT in nine Nordic transplant centers. Myeloablative…”
Get full text

Graft rejection after hematopoietic cell transplantation with nonmyeloablative conditioning by Masmas, Tania N., Petersen, Søren L., Madsen, Hans O., Ryder, Lars P., Kornblit, Brian, Svejgaard, Arne, Andersen, Pernille, Dickmeiss, Ebbe, Vindeløv, Lars L.

“…Graft rejection after hematopoietic cell transplantation (HCT) with nonmyeloablative conditioning is a rare but serious clinical problem. Graft rejection and…”
Get full text

Haematopoietic stem cell transplantation with non‐myeloablative conditioning in the outpatient setting: results, complications and admission requirements in a single institution by Petersen, Søren L., Madsen, Hans O., Ryder, Lars P., Svejgaard, Arne, Jakobsen, Bodil K., Sengeløv, Henrik, Heilmann, Carsten, Dickmeiss, Ebbe, Vindeløv, Lars L.

“…Summary Thirty patients with haematological malignancies received peripheral blood stem cells from human leucocyte antigen (HLA)‐identical sibling donors after…”
Get full text

The predictive value of helper T lymphocyte precursor frequencies for graft-versus-host disease and graft-versus-leukaemia effects in allogeneic bone marrow transplantation by RUSSELL, C. A, HEILMANN, C, MADSEN, H. O, VINDELØV, L. L

“…Helper T lymphocyte precursor (HTLp) frequencies determined by limiting dilution analysis were studied in the graft-versus-host direction to assess the…”
Get full text

Limiting dilution analysis of interleukin-2 producing helper t-cell frequencies as a tool in allogeneic hematopoietic cell transplantation by PETERSEN, Søren L, SIDOROV, Igor A, RUSSELL, Charlotte A, DICKMEISS, Ebbe, VINDELØV, Lars L

“…A reliable in vitro test that estimates the level of ongoing alloreactivity would be valuable in allogeneic hematopoietic cell transplantation (HCT) as a help…”
Get full text

Long-term survival after allogeneic haematopoietic cell transplantation for AML in remission: single-centre results after TBI-based myeloablative and non-myeloablative conditioning by Sengeløv, H, Gerds, T A, Brændstrup, P, Kornblit, B, Mortensen, B K, Petersen, S L, Vindeløv, L L

“…We report the results of non-myeloablative (NM) and myeloablative (MA) conditioning for haematopoietic cell transplantation in 207 consecutive AML patients at…”
Get full text

Design of limiting dilution analysis experiments for helper T lymphocyte precursor frequency determination in the context of allogeneic bone marrow transplantation by Russell, C.A, Brøndsted, L, Vindeløv, L.L

“…Helper, interleukin 2 (IL-2) producing, T lymphocyte precursor (HTLp) frequency determination by limiting dilution analysis (LDA) is of value for quantifying…”
Get full text

Oral cyclosporine A treatment is feasible after myeloablative conditioning in allogeneic hematopoietic stem cell transplantation by Nygaard, M., Hovgaard, D., Schjødt, I. M., Andersen, N. S., Vindeløv, L., Sengeløv, H.

“…Summary What is known and objective The target level and route of administration of cyclosporine A (CsA) differ between transplantation centres. It is unclear…”
Get full text